Nucleic Acids On-Demand World-Wide (NOW)
The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours.
The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.
The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.
Agency: Department of Defense
Office: DARPA - Biological Technologies Office
Estimated Funding: $81,498
Office: DARPA - Biological Technologies Office
Estimated Funding: $81,498
Obtain Full Opportunity Text:
FedBizOpps Announcement
Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.
See the Eligibility Information section of the BAA for more information.
Full Opportunity Web Address:
https://www.fbo.gov/index?s=opportunity&mode=form&id=e7ed37766897192c136d2d69eb057525&tab=core&_cview=1
Contact:
Agency Email Description:
lstrong@usbr.gov
Agency Email:
Date Posted:
2019-10-16
Application Due Date:
Archive Date:
2020-02-08
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
